Abstract
We describe the development of a lymphoma in a liver allograft shortly after orthotopic liver transplantation. Aspiration and core biopsies of the nodule were persistently negative so that a diagnosis could not be made until the patient underwent retransplantation, when examination of the liver resection specimen revealed a B-cell lymphoma. Using a rapid technique based on the polymerase chain reaction, we were able to demonstrate that the tumor was of donor origin.
References
Cherqui D, Duvoux C, Plassa F, Gaulard P, Julien M, Fagniez PL, Dhumeaux D, Goossens M, Farcet JP (1993) Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. Transplantation 56: 1023–1026
Fabregat J, Pradera R, Jaurrieta E, Figueras J, Rafecas A, Rufi G, Casanovas T, Casais L, Gil Vernet S (1992) Clinical results of quadruple drug immunosuppression in liver transplantation. Transplant Proc 24: 148–149
Fabregat J, Fradera R, Figueras J, Rafecas A, Torras J, Martinez Lacasa J, Baliellas C, Casais L, Jaurrieta E (1994) Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A (CsA) in liver transplantation (OLT). Incidence in viral and fungical infection. Transplant Proc 26: 2697–2699
Gambacorta M, Bonacina E, Falini B, Sabattini E, Pileri S (1991) Malignant lymphoma in the recipient of a heart transplant from a donor with malignant lymphoma. Transplantation 51: 920–922
Hjelle B, Evans-Holm M, Yen TSB, Garovoy M, Guis M, Edman JC (1989) A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation 47: 945–948
Honda H, Barloon TJ, Franken EA, Garneau RA, Smith JL (1990) Clinical and radiological features of malignant neoplasms in organ transplant recipients: cyclosporine treated vs untreated patients. AJR 154: 271–274
Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, Gonwa TA, Holman M, Klintmalm G (1993) De novo malignancy following liver transplantation: a single-center study. Transplant Proc 25: 1397–1399
Litt M, Luty JA (1990) Dinucleotide repeat polymorphism at the D6S89 locus. Nucleic Acids Res 18: 4301
Mañez R, Breinig MK, Linden P, Kusne S, Torre-Cisneros J, Wilson J, Starzl TE, Ho M (1994) Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transpl Int 7: 235–237
Meduri G, Fromentin L, Vieilefond A, Fries D (1991) Donor-related non-Hodgkin's lymphoma in a renal allograft recipient. Transplant Proc 23: 2649
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215
Moody AR, Wilson SR, Greig PD (1992) Non-Hodgkin lymphoma in the porta hepatis after orthotopic liver transplantation: sonographic findings. Radiology 182: 867–870
Palazzo JP, Lundquist K, Mitchell D, Mittal KR, Hann HWL, Muñoz S, Moritz MJ, Jacobs JM, Martin P (1993) Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis. Am J Gastroenterol 88: 102–104
Penn I (1978) Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83: 492–502
Penn I (1990) Cancers complicating organ transplantation. N Engl J Med 323: 1767–1769
Penn I (1991) The changing pattern of posttransplant malignancies. Transplant Proc 23: 1101–1103
Polson RJ, Neuberger J, Forman D, Calne R, Williams R (1988) De novo malignancies after liver transplantation. Transplant Proc 20: 94–97
Polymeropoulos MH, Rath DS, Xiao H, Merril CR (1992) Tetranucleotide repeat polymorphisms at the human beta-actin related pseudogene H-beta-Acpsi-2 (ACTBP2). Nucleic Acids Res 20: 1432
Saiki RK, Gelfand D, Stoffel S, Sharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer-direct enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491
Spiro IJ, Yandell DW, Li C, Saini S, Ferry J, Powelson J, Katkov WN, Cosimi AB (1993) Lumphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 329: 27–29
Starzl TE, Porter KA, Iwatsuki S, Rosenthal JT, Shaw BW, Atchinson RW, Nalesnik MA, Ho M, Griffith BP, Hakala TR, Hardesty RL, Jaffe R (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet I:583–587
Weber JL, May PE (1988) Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 44: 388–396
Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Corry RJ (1989) Increased frequency of post-transplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone. Transplantation 47: 293–296
Author information
Authors and Affiliations
About this article
Cite this article
Ribas, Y., Rafecas, A., Figueras, J. et al. Post-transplant lymphoma in a liver allograft. Transpl Int 8, 488–491 (1995). https://doi.org/10.1007/BF00335603
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00335603